The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

Cats are wearing hats for science—as researchers use brain scans to understand pain in arthritic felines, and find a way to ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

Like yoga mats with coils, these electromagnetic frequency-emitting devices are trending and doctors love them. Here’s the ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

Correspondence to: Dr G J Gores Mayo Clinic College of Medicine, 200 First St SW, Rochester, Minnesota 55905, USA; gores.gregorymayo.edu ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...